Back to Newsroom
Back to Newsroom

Blue Water Pain Specialists of St. Clair Shores Recognized as a Stimwave Center of Excellence

Thursday, 10 October 2019 10:00 AM

Stimwave Technologies

National program highlights innovative, minimally invasive, non-opioid treatment option for chronic pain patients.

ST. CLAIR SHORES, MI / ACCESSWIRE / October 10, 2019 / Stimwave Technologies, the leading innovator of wireless medical pain relief implant bioelectric technology, announced today that it named the Blue Water Pain Specialists of St. Clair Shores, Michigan, a Stimwave Center of Excellence as part of its national program to spotlight physicians that provide unparalleled commitment and dedication to patient outcomes.

Click here to view the full press release, including media-ready images, downloadable resources, and more.

Stimwave Technologies, Thursday, October 10, 2019, Press release picture

Stimwave Technologies, Thursday, October 10, 2019, Press release picture

 

About Blue Water Pain Specialists

Dr. Pollina started Blue Water Pain Specialists with a goal to provide outpatient pain management to improve quality of life by helping people live with chronic pain. Its skilled specialists and doctors specialize in Anesthesiology and Pain Management. Dr. Pollina is a board certified, fellowship trained Pain Medicine physician. He has been voted one of "Hour Magazine's Top Doctors" every year in practice since 2013. Dr. Pollina earned his medical degree from Wayne State University, completed his residency in anesthesiology at Northwestern University and a fellowship in pain management at the University of Michigan before coming back to the Detroit area to practice pain management. He is a member of the American Society of Anesthesiology and American Society of Regional Anesthesia and Pain Medicine.

About Stimwave

Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave's goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic burden of pain management. www.stimwave.com.

Contacts

Investors:
Mike Vallie
Westwicke, an ICR company
443-213-0499
[email protected]

Media:
Darcie Robinson
Westwicke, an ICR company
203-919-7905
[email protected]

SOURCE: Stimwave Technologies

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: